Instead, the inclusion criteria were based on a recent history of a convincing allergic reaction to cow’s milk, in conjunction with evidence of IgE-sensitization to cow’s milk, or high-level sensitization above the 95%-predictive diagnostic decision points for CMPA [19,21]. The gene discussed is IGHE; the disease is allergic disease.